Abstract
BackgroundCigarette smoking has been reported as a risk factor for early disease onset, higher disease activity, and poor function in patients (pts) with axial spondyloarthritis (SpA). Adalimumab (ADA), approved for...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
